Ronald Harold Wilfred Cooper - Jan 18, 2022 Form 4 Insider Report for ALBIREO PHARMA, INC. (ALBO)

Role
President and CEO, Director
Signature
/s/ Jason Duncan, Attorney-in-fact
Stock symbol
ALBO
Transactions as of
Jan 18, 2022
Transactions value $
$0
Form type
4
Date filed
1/20/2022, 03:49 PM
Previous filing
Sep 20, 2021
Next filing
Jan 25, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ALBO Stock Option (right to buy) Award $0 +132K $0.00 132K Jan 18, 2022 Common Stock 132K $26.75 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option vests as to 25% of the shares on January 18, 2023, with the remainder vesting in equal installments every three months thereafter beginning on April 18, 2023 and ending on January 18, 2026.